Abiopharma

News list

Cohen Joshua B 🔴 sold 7.7K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.09 Transaction Date: Jan 06, 2026 | Filing ID: 007666

Full text

News bot Jan. 8, 2026, 9:09 p.m.
🔍 Cohen Joshua B (Executive)

Company: Amylyx Pharmaceuticals, Inc. (AMLX)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 7,715
Detailed Transactions and Holdings:
- Sold 7,715 shares of Common Stock at $11.0948 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 3,317,632.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
Footnotes:
- F1: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.05 to $11.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.